FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)

FDA 510(k) K210943 · Abbott Diabetes Care, Inc.

Substantially Equivalent

510(k) numberK210943

Submission

Device name
FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)
Applicant
Abbott Diabetes Care, Inc.
Alameda, CA, US
Received
March 30, 2021
Decision date
November 22, 2021
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
QLG – Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems
Device class
Class II (moderate risk)
Regulation
21 CFR 862.1355
Specialty
Clinical Chemistry

An integrated continuous glucose monitoring system for replacement of finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes, unless otherwise indicated. The system automatically measures glucose in bodily fluids continuously or frequently for a specified period of time. The system is also designed to reliably and securely transmit glucose measurement data…

Other 510(k)s with product code QLG

510(k)DeviceApplicantDecision
K222280Bigfoot Unity® Diabetes Management SystemQLG · Traditional Bigfoot Biomedical, Inc.03/01/2023SE
K223537FreeStyle Libre 2 System, FreeStyle Libre 3 SystemQLG · Traditional Abbott Diabetes Care, Inc.02/21/2023SE
K213996FreeStyle Libre 3 Continuous Glucose Monitoring SystemQLG · Traditional Abbott Diabetes Care, Inc.05/26/2022SE
K212132FreeStyle Libre 3 Continuous Glucose Monitoring SystemQLG · Traditional Abbott Diabetes Care, Inc.05/26/2022SE
K211102FreeStyle Libre 2 Flash Glucose Monitoring SystemQLG · Traditional Abbott Diabetes Care, Inc.08/11/2021SE
K201761FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)QLG · Traditional Abbott Diabetes Care, Inc.07/30/2021SE
K202145Bigfoot Unity Diabetes Management SystemQLG · Traditional Bigfoot Biomedical, Inc.05/07/2021SE
K193371FreeStyle Libre 2 Flash Glucose Monitoring SystemQLG · Traditional Abbott Diabetes Care, Inc.06/12/2020SE

More from Abbott Diabetes Care, Inc.

510(k)DeviceDecision
K233861Libre Rio Continuous Glucose Monitoring SystemSBH · Traditional 06/07/2024SE
K233537FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose…QBJ · Traditional 04/23/2024SE
K223435FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose…QBJ · Traditional 04/13/2023SE
K222447FreeStyle Libre 2 Flash Glucose Monitoring System; Freestyle Libre 3 Continuous Glucose…QBJ · Traditional 03/03/2023SE
K223537FreeStyle Libre 2 System, FreeStyle Libre 3 SystemQLG · Traditional 02/21/2023SE
K213996FreeStyle Libre 3 Continuous Glucose Monitoring SystemQLG · Traditional 05/26/2022SE
K212132FreeStyle Libre 3 Continuous Glucose Monitoring SystemQLG · Traditional 05/26/2022SE
K211102FreeStyle Libre 2 Flash Glucose Monitoring SystemQLG · Traditional 08/11/2021SE
K201761FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)QLG · Traditional 07/30/2021SE
K193371FreeStyle Libre 2 Flash Glucose Monitoring SystemQLG · Traditional 06/12/2020SE

Questions and answers

When was FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App) cleared by the FDA?

FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App) (K210943) received a 510(k) decision of Substantially Equivalent on November 22, 2021, 237 days after the submission was received.

What is the product code of K210943?

The FDA product code is QLG – Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems, a Class II (moderate risk) device regulated under 21 CFR 862.1355.